title: [An experience with dose-escalated conformal radiation therapy in hormone-radiotherapy for prostate cancer].
abstract: This study presents the short-term outcomes of conformal external beam radiation therapy given in conjunction with hormone therapy to 110 patients with prostate cancer. We performed a comparative analysis of the rate and degree of radiation reactions and complications following delivery of a total dose of 70 Gy and 72-76 Gy to the tumor. In prostate cancer, a continuous course of dose-escalated conformal radiation therapy resulted in satisfactory tolerance and acceptable levels of late complications.
authors.forename: Yu V
authors.initials: YV
authors.lastname: Gumenetskaya
authors.forename: Yu S
authors.initials: YS
authors.lastname: Mardynsky
authors.forename: O B
authors.initials: OB
authors.lastname: Karyakin
authors.forename: I A
authors.initials: IA
authors.lastname: Gulidov
authors.forename: V A
authors.initials: VA
authors.lastname: Biryukov
mesh_terms: D000208:Acute Disease; D000230:Adenocarcinoma / Q000188:drug therapy* / Q000532:radiotherapy*; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D003556:Cystitis / Q000209:etiology*; D006801:Humans; D021621:Imaging, Three-Dimensional; D008297:Male; D008875:Middle Aged; D011349:Proctitis / Q000209:etiology*; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D011832:Radiation Injuries / Q000209:etiology*; D011879:Radiotherapy Dosage; D020266:Radiotherapy, Conformal / Q000379:methods*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D018931:Antineoplastic Agents, Hormonal